Vivoryon Therapeutics NV
AEX:VVY

Watchlist Manager
Vivoryon Therapeutics NV Logo
Vivoryon Therapeutics NV
AEX:VVY
Watchlist
Price: 1.46 EUR -1.35% Market Closed
Market Cap: 43.2m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of VVY.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VVY Intrinsic Value
Not Available
Base Case Scenario
Compare VVY to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VVY?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vivoryon Therapeutics NV

Current Assets 5.2m
Cash & Short-Term Investments 4.9m
Receivables 150k
Other Current Assets 223k
Non-Current Assets 1.2m
PP&E 90k
Intangibles 830k
Other Non-Current Assets 260k
Current Liabilities 1.3m
Accounts Payable 1m
Accrued Liabilities 210k
Other Current Liabilities 60k
Non-Current Liabilities 1.9m
Long-Term Debt 10k
Other Non-Current Liabilities 1.9m
Efficiency

Free Cash Flow Analysis
Vivoryon Therapeutics NV

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vivoryon Therapeutics NV

Revenue
0 EUR
Operating Expenses
-12.7m EUR
Operating Income
-12.7m EUR
Other Expenses
200k EUR
Net Income
-12.5m EUR
Fundamental Scores

VVY Profitability Score
Profitability Due Diligence

Vivoryon Therapeutics NV's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Strong 3Y Average Operating Margin
Strong 3Y Average Net Margin
Sustainable 3Y Average Gross Margin
42/100
Profitability
Score

Vivoryon Therapeutics NV's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

VVY Solvency Score
Solvency Due Diligence

Vivoryon Therapeutics NV's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
63/100
Solvency
Score

Vivoryon Therapeutics NV's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VVY Price Targets Summary
Vivoryon Therapeutics NV

Wall Street analysts forecast VVY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VVY is 4.93 EUR with a low forecast of 2.02 EUR and a high forecast of 7.88 EUR.

Lowest
Price Target
2.02 EUR
38% Upside
Average
Price Target
4.93 EUR
238% Upside
Highest
Price Target
7.88 EUR
439% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Vivoryon Therapeutics NV
does not pay dividends
Shareholder Yield

Current shareholder yield for VVY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y